Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis
<h3>Introduction</h3><p dir="ltr">Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. The...
Saved in:
| Main Author: | Nancy Kassem (3517106) (author) |
|---|---|
| Other Authors: | Ahmed A. Ghazy (16555849) (author), Mohammad Abu-Tineh (14829313) (author), Nabil E. Omar (16555850) (author), Abdulqadir J. Nashwan (16328993) (author), Prem Chandra (9072038) (author), Rola Ghasoub (16555851) (author), Osama S. AbuTabar (16555854) (author), Mohamed A. Yassin (16322749) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs) and Ultrasound.
by: Ibrahim, Mihad
Published: (2016) -
Biologic characterization of atypical chronic lymphocytic leukaemia
by: Dina S. Soliman (14779333)
Published: (2021) -
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
by: Maria Benkhadra (19756941)
Published: (2024) -
Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
by: Abdulrahman F. Al-Mashdali (17148316)
Published: (2022) -
Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the diverse applications of machine learning
by: Mohamed Elhadary (16329082)
Published: (2023)